Hims to stop offering GLP-1 pill after FDA warned of crackdown
By Anusha Shah and Amina Niasse
Feb 7 (Reuters) - Online telehealth company Hims & Hers on Saturday reversed course on its launch of a $49 compounded version of Novo Nordisk's Wegovy weight-loss pill after the U.S. Food and Drug Administration said it would take... Read More.


